Non-hepatic Cancers Independently Predict Liver Decompensation Events

Area of Science:

• Hepatology
• Oncology
• Medical Prognostics

Background:

• Advanced liver fibrosis and cirrhosis are established risk factors for hepatocellular carcinoma (HCC).
• Chronic liver disease etiologies like NAFLD, alcohol abuse, and hepatitis C infection are linked to increased non-hepatic cancer risk.
• Understanding cancer incidence and its prognostic impact in chronic liver disease is crucial.

Purpose of the Study:

• To characterize cancer incidence in patients with chronic liver disease.
• To assess the prognostic value of non-hepatic cancer on decompensation events in this population.

Main Methods:

• Retrospective review of electronic medical records for patients undergoing transient elastography (TE).
• Identification of patients with cirrhosis decompensation and extraction of cancer history.
• Univariate and multivariate Cox regression analysis and Kaplan-Meier curves to determine risk factors and prognostic significance.

Main Results:

• A total of 3097 patients were analyzed, with 45 documented liver decompensation events.
• MELD-Na score, liver stiffness measurement, and history of any cancer were significant predictors of decompensation.
• Non-hepatic cancer independently predicted decompensation events (HR 3.57, p=0.002).

Conclusions:

• This study is the first to describe cancer incidence in this high-risk population.
• Non-HCC cancers independently predict hepatic decompensation events.
• Physicians should consider cancer history for prognostic information and to guide individualized treatment and surveillance plans for chronic liver disease patients.